Cadazolid (ACT-179811)|cas 1025097-10-2

Cadazolid (ACT-179811)|cas 1025097-10-2

DC Chemicals, Website: www.dcchemicals.com

Product Name: Cadazolid (ACT-179811)|Cas Number: 1025097-10-2| Catalog Number: DC10457|Other Nmaes: ACT-179811; ACT 179811; ACT179811; Cadazolid.

Cadazolid (ACT-179811) is a novel fluoroquinolone-oxazolidinone antibiotic and a protein synthesis inhibitor.

Cadazolid, also known ACT-179811, is a novel fluoroquinolone-oxazolidinone antibiotic and a protein synthesis inhibitor. Cadazolid may be potentially useful for the treatment of Clostridium difficile infection. Cadazolid exhibits potent in vitro activity against Clostridium difficile, including the epidemic BI/NAP1/027 strain. Clostridium difficile infection (CDI), the main cause of nosocomial infectious diarrhea, results from the growth of toxin-producing C. difficile in the colon following disruption of the normal enteric microbiota, usually as a consequence of antibiotic therapy.